AnalyticsIQ and Diaceutics Partner to Launch Breakthrough Healthcare Audience Targeting
Sarah Heming
New co-developed healthcare audience targeting combines condition-level treatment insights with personal behavioral data to power smarter engagement strategies.
We are delighted to announce our latest partnership with AnalyticsIQ! This collaboration launches breakthrough healthcare audience targeting. AnalyticsIQ is the leading people-based data innovator. We are a leading technology and solutions provider to the pharmaceutical and biotech industry.
Together, we will deliver a new generation of high-impact healthcare audience targeting. We aim to revolutionize how life sciences brands engage and market to providers. Through this collaboration, we have co-developed advanced healthcare audience segments. This unites AnalyticsIQ's predictive behavioral insights on HCPs with our multimodal clinical data.
This powerful combination of innovative datasets empowers pharma marketers to reach HCPs, not just based on what they treat but who they are as individuals. This new way of healthcare audience targeting will blend:
- AnalyticsIQ's provider-as-a-person intelligence. This predicts behavioral, attitudinal, and communication preferences.
- Diaceutics' real-world lab and genomic testing insights.
Together, this delivers unprecedented visibility into a provider’s mindset and the patient populations they serve.
These co-developed audiences will initially be available for activation in DeepIntent’s Audience Marketplace and the Doceree Marketplace. Availability across leading healthcare marketing platforms will be coming soon.
Audience Attributes Include:
Predictive personal insights from AnalyticsIQ’s Provider-as-a-Person Intelligence, including:
- Tech-forward and early-adopter HCPs
- Bilingual (English/Spanish) providers
- Frequent podcast listeners
- HCPs who make business decisions within their organizations
Diaceutics delivers clinically rich patient and HCP insights across a range of therapeutic areas including:
- Chronic diseases guided by lab-based diagnostics such as diabetes, hypercholesterolemia, and rheumatoid arthritis
- Patients with precision medicine targeted therapies in breast, lung, and prostate cancers
- Biomarker-specific segments, including HER2+, EGFR+, PDL1+, and more
This new capability for healthcare audience targeting will offer a suite of 80+ curated HCP audiences. It offers a dual lens into a provider's clinical focus and the HCP as a consumer, including personal engagement style. It will enable more personalized, data-driven strategies that resonate.
“With Provider-as-a-Person Intelligence, our mission has always been to help marketers understand healthcare providers beyond their credentials. By combining our people-based insights with Diaceutics’ world-class clinical data, we’re enabling pharma brands to finally personalize engagement at both the clinical and human level. Unlocking smarter strategies and better outcomes.”
– Christine Lee, Head of Health Strategy at AnalyticsIQ.
According to the CDC, 70% of clinical decisions are based on diagnostic test results. This level of intelligence allows marketers to make smarter healthcare audience targeting decisions. From here, they can engage clinically relevant HCPs on the right channels, with messaging that resonates. And ultimately it drives the adoption of the right therapies to improve patient outcomes.
“This partnership is a natural extension of our commitment to improving patient outcomes through precision medicine. By linking our real-world diagnostic and treatment insights with AnalyticIQ’s behavioral intelligence, we’re enabling life science teams to identify and activate the right providers. They can use messaging that truly resonates and ensure providers feel empowered to make the right decisions from the start.”
– Scott Phillips, VP of Real World Data at Diaceutics.
With this collaboration, we are setting a new standard for HCP audience targeting and intelligence. We are uniting two powerful data dimensions in a single solution for the first time. This innovative approach positions pharma and life sciences marketers at the forefront of precision engagement. We are equipping them to lead the way in connecting with providers in more meaningful, impactful ways.
About Diaceutics
Our ethos is that every patient deserves access to the right tests and therapies, for the best possible disease outcome. For close to 20 years, we have worked with the world’s top pharma and biotechs. Our specialism is in delivering precision medicine and diagnostic solutions. By bridging the gap between biomarker testing and targeted therapies, Diaceutics empowers industry partners to succeed in the evolving field of personalized healthcare.
About AnalyticsIQ
AnalyticsIQ is the leading people-based marketing data creator and predictive analytics innovator. Their mission is to fuel better outcomes for all by creating high-quality and predictive people-based data. They do this by blending cognitive psychology with data science. This helps organizations understand the people behind the data; what they do and why they make decisions.
Their PeopleCore consumer data is a suite of SDOH insights. As a Provider-as-a-Person Intelligence, it unlocks insight into patients and HCPs as people. These are people who are empowering healthcare organizations. They enhance engagement, power research, and ultimately achieve better outcomes.
AnalyticsIQ helps improve patient and HCP engagement across multiple channels. It builds predictive models and custom audiences.
About Diaceutics
We’ve been with pharma and biotech companies for over 20 years, helping them to make more informed diagnostic and therapeutic decisions based on real-world data. Our platforms and tools provide global insight from a network of laboratories across 50+ countries.
This unparalleled visibility into real-world testing helps support therapy programs across oncology, cardiology, neurology, autoimmune, rare diseases, and many more.
FAQS
What is the Diaceutics and AnalyticsIQ partnership?
Diaceutics and AnalyticsIQ have co-developed a new generation of healthcare audience segments. They combine AnalyticsIQ's predictive behavioral insights on HCPs with Diaceutics' multimodal clinical data. It is the first time these two data dimensions have been united in a single solution.
What is provider-as-a-person intelligence?
Provider-as-a-person intelligence is AnalyticsIQ's approach to understanding healthcare providers beyond their credentials. It predicts behavioral, attitudinal and communication preferences. Marketers can reach HCPs based not just on what they treat, but on who they are as individuals.
How does healthcare audience targeting combine clinical and behavioral data?
The audiences give a dual lens into a provider's clinical focus and the HCP as a consumer, including their personal engagement style. AnalyticsIQ contributes predictive personal insights. Diaceutics contributes real-world lab and genomic testing insights. Together they give visibility into a provider's mindset and the patient populations they serve.
What audience attributes are available?
The suite includes 80+ curated HCP audiences. AnalyticsIQ attributes include tech-forward and early-adopter HCPs, bilingual (English/Spanish) providers, frequent podcast listeners, and HCPs who make business decisions within their organizations. Diaceutics segments cover:
- Chronic diseases guided by lab-based diagnostics, such as diabetes, hypercholesterolemia and rheumatoid arthritis
- Precision medicine targeted therapies in breast, lung and prostate cancers
- Biomarker-specific segments, including HER2+, EGFR+, PDL1+ and more
Where can marketers activate these audiences?
The co-developed audiences are initially available in DeepIntent's Audience Marketplace and the Doceree Marketplace. Availability across other leading healthcare marketing platforms is coming soon.